Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis.
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
Intertwining extracellular nucleotides and their receptors with Ca2+ in determining adult neural stem cell survival, proliferation and final fate.
Transcriptomic analyses of genes and tissues in inherited sensory neuropathies.
Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.
Antiglutamatergic therapy for multiple sclerosis?
Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring.
Neural correlates of sensory gating in the rat: decreased Fos induction in the lateral septum.
Mevalonate Cascade and small Rho GTPase in Spinal Cord Injury.
Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.
Severe, Highly Active, or Aggressive Multiple Sclerosis.
Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
A survey study comparing young adults with MS and healthy controls on self-esteem, self-efficacy, mood and quality of life.
Imaging of microglial activation in MS using PET: Research use and potential future clinical application.
Engineering three dimensional micro nerve tissue using postnatal stem cells from human dental apical papilla.
An Unanticipated Pattern of Sleep-Disordered Breathing in a Patient with Multiple Sclerosis.
Concomitant Guillain Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric Manifestation in a Case of Lupus: A Diagnostic Quandary.
Increased expression of Tbet in CD4(+) T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS.
NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.
Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia.
Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Pages
« first
‹ previous
…
735
736
737
738
739
740
741
742
743
…
next ›
last »